Cargando…

Nandrolone decanoate: new therapeutic option for telomeropathies?

Detalles Bibliográficos
Autor principal: Frieri, Camilla
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Fondazione Ferrata Storti 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10388256/
https://www.ncbi.nlm.nih.gov/pubmed/36815395
http://dx.doi.org/10.3324/haematol.2022.282540
_version_ 1785082073264947200
author Frieri, Camilla
author_facet Frieri, Camilla
author_sort Frieri, Camilla
collection PubMed
description
format Online
Article
Text
id pubmed-10388256
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Fondazione Ferrata Storti
record_format MEDLINE/PubMed
spelling pubmed-103882562023-08-01 Nandrolone decanoate: new therapeutic option for telomeropathies? Frieri, Camilla Haematologica Editorial Fondazione Ferrata Storti 2023-02-23 /pmc/articles/PMC10388256/ /pubmed/36815395 http://dx.doi.org/10.3324/haematol.2022.282540 Text en Copyright© 2023 Ferrata Storti Foundation https://creativecommons.org/licenses/by-nc/4.0/This article is distributed under the terms of the Creative Commons Attribution Noncommercial License (by-nc 4.0) which permits any noncommercial use, distribution, and reproduction in any medium, provided the original author(s) and source are credited.
spellingShingle Editorial
Frieri, Camilla
Nandrolone decanoate: new therapeutic option for telomeropathies?
title Nandrolone decanoate: new therapeutic option for telomeropathies?
title_full Nandrolone decanoate: new therapeutic option for telomeropathies?
title_fullStr Nandrolone decanoate: new therapeutic option for telomeropathies?
title_full_unstemmed Nandrolone decanoate: new therapeutic option for telomeropathies?
title_short Nandrolone decanoate: new therapeutic option for telomeropathies?
title_sort nandrolone decanoate: new therapeutic option for telomeropathies?
topic Editorial
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10388256/
https://www.ncbi.nlm.nih.gov/pubmed/36815395
http://dx.doi.org/10.3324/haematol.2022.282540
work_keys_str_mv AT friericamilla nandrolonedecanoatenewtherapeuticoptionfortelomeropathies